Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9

Hemophilia A (HA) is caused by genetic mutations in the blood coagulation factor VIII (FVIII) gene. Genome-editing approaches can be used to target the mutated site itself in patient-derived induced pluripotent stem cells (iPSCs). However, these approaches can be hampered by difficulty in preparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Chul-Yong, Sung, Jin Jea, Cho, Sung-Rae, Kim, Jongwan, Kim, Dong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565751/
https://www.ncbi.nlm.nih.gov/pubmed/31105049
http://dx.doi.org/10.1016/j.stemcr.2019.04.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565751/
https://www.ncbi.nlm.nih.gov/pubmed/31105049
http://dx.doi.org/10.1016/j.stemcr.2019.04.016

Ejemplares similares